HAP Trading’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$176K Buy
67,500
+7,500
+13% +$802K 0.01% 427
2025
Q2
$167K Hold
60,000
0.02% 354
2025
Q1
$540K Buy
+60,000
New +$6.72M 0.06% 177
2022
Q2
Sell
-78,300
Closed -$356K 1966
2022
Q1
$356K Buy
78,300
+62,500
+396% +$10.5M 0.01% 651
2021
Q4
$361K Sell
15,800
-14,200
-47% -$3.89M 0.01% 806
2021
Q3
$793K Buy
30,000
+13,000
+76% +$4.13M 0.03% 534
2021
Q2
$138K Buy
17,000
+3,200
+23% +$603K ﹤0.01% 1114
2021
Q1
$226K Sell
13,800
-15,500
-53% -$1.65M 0.01% 728
2020
Q4
$820K Buy
29,300
+16,400
+127% +$1.61M 0.02% 475
2020
Q3
$82K Buy
+12,900
New +$926K ﹤0.01% 842

Other funds holding BNTX

HAP Trading's BNTX Position: Q1 2021 in Review

HAP Trading sold out of BioNTech (BNTX) in Q1 2021, closing a stake of 12,962 shares — an estimated $1.38M sold.

HAP Trading first reported a position in BNTX in Q4 2020 and held it in 1 quarter. The position peaked at $1.06M in Q4 2020. 225 funds tracked by Wall St. Rank hold BNTX as of Q1 2021.

  • HAP Trading reported no remaining BioNTech position as of Q1 2021 after selling out during the quarter.
  • HAP Trading sold 12,962 BioNTech shares in Q1 2021, an estimated $1.38M.
  • HAP Trading first reported a position in BioNTech in Q4 2020 and held it in 1 quarter.
  • HAP Trading's BioNTech position peaked at $1.06M in Q4 2020.
  • 225 funds tracked by Wall St. Rank held BioNTech as of Q1 2021.

Based on HAP Trading's 13F filing for Q1 2021, filed 14 May 2021.